Al's Comment:

 This is a real head scratcher - why did those with a worse prognosis do better than those with the better prognosis?
The drug clearly has an effect.  We need further research to see if a combination approach targeting the other mutations they mention may make a big response.


Posted on: 10/31/2026

Proteasome inhibitor primes temozolomide response in a molecular subset of recurrent glioblastoma

 


Click HERE to return to brain tumor news headlines.


Our Terms of Use and Privacy Policy has changed.
Click HERE to read it!